|
|
Volumn 20, Issue 9, 2002, Pages 2360-2364
|
|
Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: A gynecologic oncology group study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
FOLINIC ACID;
PACLITAXEL;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANEMIA;
ANOREXIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG TOLERABILITY;
ENDOMETRIUM CANCER;
ESOPHAGITIS;
FEMALE;
FEVER;
GASTROINTESTINAL TOXICITY;
HEMATURIA;
HUMAN;
LEUKOCYTE COUNT;
LEUKOPENIA;
LUNG TOXICITY;
METASTASIS;
MUCOSA INFLAMMATION;
NAUSEA;
NEUROTOXICITY;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RECURRENT CANCER;
SKIN MANIFESTATION;
THROMBOCYTOPENIA;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VOMITING;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
DOXORUBICIN;
ENDOMETRIAL NEOPLASMS;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
LIPOSOMES;
MIDDLE AGED;
NEOPLASM METASTASIS;
TREATMENT OUTCOME;
|
|
EID: 0036569847
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2002.08.171 Document Type: Article |
|
Times cited : (159)
|
|
References (16)
|
